Based on the add'l info rec'd on (b)(4) 2014, this case initially considered as non-serious was upgraded to serious as the pt experienced disabling events of "difficulty in walking/ dragging of knee", "unable to drive and daily normal activities" and "swelling in left knee." this unsolicited device case was rec'd from (b)(4) on (b)(6) 2014 from rheumatologist via sales rep.Based on the add'l info rec'd on (b)(4) 2014 from a physiotherapist, the events of vomiting, stomach ache, difficulty in walking/ dragging of knee, unable to drive and daily normal activities and swelling in left knee were added.This case involves an adult female pt (age not provided) who experienced increase in pain, vomiting, stomach aches, difficulty walking/ dragging of knee, unable to drive and daily normal activities and swelling in left knee after receiving synvisc one injection.The pt's medical history, past drugs and concomitant conditions were not reported.Pt had concurrent condition of pain.On (b)(6) 2013, the pt rec'd treatment with intra-articular synvisc one injection, at a dose of 06 ml, once (batch/lot number and expiration date not provided) into unspecified knee for knee osteoarthritis.The same day, the pt underwent episodes of vomiting, stomach ache post injection along with considerable swelling in the left knee.However, on (b)(6) 2013, after 3 days, the pt recovered from the event of vomiting.It was reported that swelling was removed for a period of one month.On an unk date, the pt experienced difficulty in walking resulting in dragging of knee because of which she was unable to drive and perform daily normal activities.Corrective treatment: domperidone for the event of swelling in left knee.Outcome: recovered/ resolved for the event of vomiting.Not recovered/ not resolved for the events of difficulty in walking/ dragging of knee, unable to drive and daily normal activities, swelling in left knee and stomach ache.Unk for the event of increase in pain.A pharmaceutical technical complaint (ptc) was initiated with global ptc number: (b)(4) and conclusion was pending for the same.Seriousness criteria: significant disability/ incapacity for the events of "difficulty in walking/ dragging of knee", "unable to drive and daily normal activities" and "swelling in left knee." rptr's causality: probable for swelling of left knee, difficulty in walking/dragging of knee, unable to drive and daily normal activities.Add'l info was rec'd on (b)(4) 2014 from a physiotherapist.The therapy details for synvisc one injection (start date, route of administration, dosage regime and indication) were updated.The treatment medication of domperidone was added.The events of vomiting, stomach ache, difficulty in walking/ dragging of knee, unable to drive and daily normal activities and swelling in left knee were added.Subsequently, the pt's clinical course was amended accordingly.
|